Astellas Pharma Inc.

Company Snapshot

Founded: 1923

Entity Type: Public

Employees: 13,643

Region: U.S.

Revenue: $12,564.0 Millions

Revenue Year: 2024

Headquarter: Tokyo, Japan

Key Geographics: Japan, U.S., Others

Corporate Address: 2-5-1, Nihonbashi-Honcho, Chuo-Ku, Tokyo 103-8411, Japan Tel. +81-3-3244-3000 www.astellas.com

Company Overview

Astellas Pharma Inc. was established in 1923 and is headquartered in Tokyo, Japan. Astellas Pharma, one of Japan’s leading prescription drug companies, manufactures products for cardiovascular and diabetes, central nervous system, infectious diseases, inflammation and motor organs, urology, and oncology. Astellas conducts business in more than 70 countries and regions around the world.

Astellas' drug discovery process spans basic science to pre-clinical research, where internal teams collaborate with external partners to identify drug opportunities and develop clinical candidates. Clinical trials are then conducted in the development phase to evaluate the efficacy and safety of these candidates before regulatory approval for patient use.

The company also emphasizes lifecycle management, continuously seeking opportunities to improve products based on feedback from healthcare professionals. It understands the global problem of access to healthcare and dedicates itself to using its expertise to provide available medicines and solutions to healthcare access for the unreached.

Financial Highlights (FY 2024)

Net Revenue: ***

Total Current Liabilities: ***

Total Current Assets: ***

R&D expenses: ***

Operating Income: ***

This information is available for BCC Research members only.

Already a Member? Sign In Become a Member